NCT00040508View on ClinicalTrials.gov

Sirolimus for Focal Segmental Glomerulosclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

January 31, 2005

Conditions
Focal Glomerulosclerosis
Interventions
DRUG

Sirolimus

Trial Locations (1)

20892

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00040508 - Sirolimus for Focal Segmental Glomerulosclerosis | Biotech Hunter | Biotech Hunter